S-3ASR · 2026-11-10
Kura Oncology, Inc. has registered to offer up to $150 million in securities, including common stock and debt, to support its cancer treatment initiatives.
| Name | Kura Oncology, Inc. |
|---|---|
| CIK | 0001422143 |
| Tickers | KURA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 611547851 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858) 500-8800 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Kura Oncology, Inc. has registered to offer up to $150 million in securities, including common stock and debt, to support its cancer treatment initiatives.
828 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 4 | 4 | 0001193125-26-468898 | 4882 | ||||||
| 2026-11-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011354 | 001-37620 | 261575191 | 33 | 8423 | |||
| 2026-11-18 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-26-001602 | 021-605234 | 261571165 | 33 | 16890 | ||
| 2026-11-18 | 4 | 4 | 0001193125-26-467083 | 15907 | ||||||
| 2026-11-18 | 4 | 4 | 0001193125-26-467081 | 17177 | ||||||
| 2026-11-18 | 4 | 4 | 0001193125-26-467080 | 16759 | ||||||
| 2026-11-18 | 4 | 4 | 0001193125-26-467078 | 14959 | ||||||
| 2026-11-18 | 4 | 4 | 0001193125-26-467076 | 17161 | ||||||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011249 | 001-37620 | 261566715 | 33 | 7719 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011229 | 001-37620 | 261566546 | 33 | 6981 | |||
| 2026-11-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011228 | 001-37620 | 261566542 | 33 | 6978 | |||
| 2026-11-17 | 4/A | 4/A | 0001193125-26-465499 | 9205 | ||||||
| 2026-11-16 | 4 | 4 | 0001193125-26-464166 | 18310 | ||||||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-464154 | 001-37620 | 261563561 | 33 | 14495 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-464153 | 001-37620 | 261563559 | 33 | 14432 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-464152 | 001-37620 | 261563560 | 33 | 13787 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-464150 | 001-37620 | 261563558 | 33 | 15852 | |||
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-464151 | 001-37620 | 261563557 | 33 | 14493 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-003183 | 005-83933 | 261561304 | 34 | 23773 | |||
| 2026-11-10 | S-3ASR | S-3ASR | 0001193125-26-455759 | 333-299972 | 261541580 | 33 | 2351330 | 1 | 1 | |
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-455455 | 001-37620 | 261540438 | 34 | 10686056 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-455416 | 001-37620 | 261540252 | 34 | 503650 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003813 | 005-83933 | 261491642 | 34 | 11114 | |||
| 2026-09-29 | 4 | 4 | 0001193125-26-407939 | 5405 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-407938 | 7592 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-407937 | 7593 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-407936 | 6318 | ||||||
| 2026-09-29 | 4 | 4 | 0001193125-26-407935 | 9154 | ||||||
| 2026-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009866 | 001-37620 | 261424178 | 33 | 6982 | |||
| 2026-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009865 | 001-37620 | 261424173 | 33 | 5562 | |||
| 2026-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009864 | 001-37620 | 261424168 | 33 | 5553 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-405751 | 001-37620 | 261418848 | 33 | 5715 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-405713 | 001-37620 | 261418761 | 33 | 4313 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-405712 | 001-37620 | 261418760 | 33 | 4997 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-405711 | 001-37620 | 261418758 | 33 | 4313 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-405710 | 001-37620 | 261418757 | 33 | 4322 | |||
| 2026-09-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009845 | 001-37620 | 261417500 | 33 | 5561 | |||
| 2026-09-25 | 4 | 4 | 0001193125-26-402815 | 8979 | ||||||
| 2026-09-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009786 | 001-37620 | 261404821 | 33 | 4814 | |||
| 2026-09-10 | 4 | 4 | 0001193125-26-387934 | 5516 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-387926 | 13389 | ||||||
| 2026-09-09 | 8-K | 8-K | 8.01 | 0001193125-26-385881 | 001-37620 | 261366654 | 34 | 142418 | 1 | 1 |
| 2026-09-08 | 8-K | 8-K | 5.02 | 0001193125-26-384363 | 001-37620 | 261363351 | 34 | 144518 | 1 | 1 |
| 2026-08-24 | 4 | 4 | 0001193125-26-363812 | 6569 | ||||||
| 2026-08-24 | 4 | 4 | 0001193125-26-363810 | 5349 | ||||||
| 2026-08-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008548 | 001-37620 | 261305261 | 33 | 5006 | |||
| 2026-08-21 | 4 | 4 | 0001193125-26-361184 | 5465 | ||||||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008396 | 001-37620 | 261295488 | 33 | 5013 | |||
| 2026-08-17 | 4 | 4 | 0001193125-26-354201 | 6569 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005536 | 005-83933 | 261282274 | 34 | 16816 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346884 | 001-37620 | 261267683 | 34 | 7930496 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-346856 | 001-37620 | 261267564 | 34 | 528321 | 1 | 1 |
| 2026-07-29 | 8-K | 8-K | 5.02 | 0001193125-26-324202 | 001-37620 | 261218814 | 34 | 144050 | 1 | 1 |
| 2026-06-22 | 4 | 4 | 0001193125-26-277780 | 5526 | ||||||
| 2026-06-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006310 | 001-37620 | 261102992 | 33 | 5025 | |||
| 2026-06-04 | 4 | 4 | 0001193125-26-257903 | 5321 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257902 | 5382 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257901 | 5359 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257900 | 5337 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257898 | 5322 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257897 | 5334 | ||||||
| 2026-06-04 | 4 | 4 | 0001193125-26-257896 | 5371 | ||||||
| 2026-06-04 | S-8 | S-8 | 0001193125-26-257777 | 333-296511 | 261066078 | 33 | 465083 | 1 | 1 | |
| 2026-06-04 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-257368 | 001-37620 | 261064888 | 34 | 926749 | 1 | 1 |
| 2026-05-26 | DEFA14A | DEFA14A | 0001193125-26-239481 | 001-37620 | 261020541 | 34 | 45670 | |||
| 2026-05-22 | 4 | 4 | 0001193125-26-236838 | 4884 | ||||||
| 2026-05-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004907 | 001-37620 | 261009056 | 33 | 5559 | |||
| 2026-05-20 | 4 | 4 | 0001193125-26-232547 | 5059 | ||||||
| 2026-05-20 | 4 | 4 | 0001193125-26-232548 | 5523 | ||||||
| 2026-05-20 | 4 | 4 | 0001193125-26-232546 | 5499 | ||||||
| 2026-05-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004793 | 001-37620 | 26999677 | 33 | 4854 | |||
| 2026-05-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004789 | 001-37620 | 26999615 | 33 | 4845 | |||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004689 | 001-37620 | 26994061 | 33 | 4855 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002164 | 005-83933 | 26984228 | 34 | 10671 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219481 | 001-37620 | 26968753 | 34 | 7159617 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-219422 | 001-37620 | 26968573 | 34 | 448245 | 1 | 1 |
| 2026-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000682 | 005-83933 | 26921294 | 34 | 7493 | |||
| 2026-04-10 | ARS | ARS | 0001193125-26-151391 | 001-37620 | 26855484 | 34 | 1788624 | |||
| 2026-04-10 | DEFA14A | DEFA14A | 0001193125-26-151363 | 001-37620 | 26855384 | 34 | 6327396 | |||
| 2026-04-10 | DEF 14A | DEF 14A | 0001193125-26-151335 | 001-37620 | 26855203 | 34 | 15528880 | 1 | 1 | |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001712 | 005-83933 | 26801939 | 34 | 7258 | |||
| 2026-03-25 | 4 | 4 | 0001193125-26-122938 | 8367 | ||||||
| 2026-03-20 | 4 | 4 | 0001193125-26-116834 | 7709 | ||||||
| 2026-03-05 | 10-K | 10-K | 0001193125-26-092567 | 001-37620 | 26724204 | 34 | 17551883 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-092465 | 001-37620 | 26724120 | 34 | 495765 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001243 | 005-83933 | 26645089 | 34 | 10475 | |||
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-26-000062 | 005-83933 | 26609559 | 34 | 8114 | |||
| 2026-01-29 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-029705 | 001-37620 | 26579440 | 34 | 356993 | 1 | 1 |
| 2026-01-27 | 4 | 4 | 0001193125-26-025305 | 6274 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-025304 | 4720 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-025303 | 9387 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-025302 | 11652 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-025306 | 4726 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-025301 | 7804 | ||||||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025296 | 001-37620 | 26568026 | 33 | 4766 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025295 | 001-37620 | 26568024 | 33 | 5207 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025294 | 001-37620 | 26568023 | 33 | 4312 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025293 | 001-37620 | 26568019 | 33 | 5681 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025292 | 001-37620 | 26568018 | 33 | 4318 | |||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-025291 | 001-37620 | 26568017 | 33 | 6151 | |||
| 2026-01-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-009649 | 001-37620 | 26524537 | 34 | 204769 | 1 | 1 |
| 2026-01-06 | 4 | 4 | 0001193125-26-004580 | 5302 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004570 | 6916 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004569 | 7807 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004567 | 6921 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004566 | 5302 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004564 | 6919 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-004562 | 6891 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326948 | 8920 | ||||||
| 2025-12-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010487 | 001-37620 | 251583112 | 33 | 4814 | |||
| 2025-12-10 | 4 | 4 | 0001193125-25-314154 | 6556 | ||||||
| 2025-12-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010004 | 001-37620 | 251559378 | 33 | 4851 | |||
| 2025-12-02 | 8-K | 8-K | 8.01 | 0001193125-25-304559 | 001-37620 | 251541638 | 34 | 139632 | 1 | 1 |
| 2025-11-14 | 4 | 4 | 0001193125-25-283568 | 6633 | ||||||
| 2025-11-14 | 4 | 4 | 0001193125-25-283565 | 6680 | ||||||
| 2025-11-14 | 4 | 4 | 0001193125-25-283564 | 6252 | ||||||
| 2025-11-14 | 4 | 4 | 0001193125-25-283563 | 6676 | ||||||
| 2025-11-14 | 4 | 4 | 0001193125-25-283562 | 7365 | ||||||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-283567 | 001-37620 | 251488974 | 33 | 4313 | |||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-283566 | 001-37620 | 251488973 | 33 | 4322 | |||
| 2025-11-14 | 4 | 4 | 0001193125-25-283560 | 6659 | ||||||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-283561 | 001-37620 | 251488972 | 33 | 4309 | |||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-283559 | 001-37620 | 251488971 | 33 | 4291 | |||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-283558 | 001-37620 | 251488970 | 33 | 4312 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005180 | 005-83933 | 251488782 | 34 | 10736 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-003106 | 005-83933 | 251486268 | 34 | 25054 | |||
| 2025-11-13 | 8-K | 8-K | 8.01 | 0001193125-25-280255 | 001-37620 | 251478979 | 34 | 145848 | 1 | 1 |
| 2025-11-04 | S-8 | S-8 | 0001193125-25-263599 | 333-291242 | 251446471 | 33 | 179308 | 1 | 1 | |
| 2025-11-04 | 10-Q | 10-Q | 0001193125-25-263589 | 001-37620 | 251446458 | 34 | 8087701 | 1 | 1 | |
| 2025-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-263491 | 001-37620 | 251446307 | 34 | 427736 | 1 | 1 |
| 2025-10-24 | 8-K | 8-K | 8.01 | 0001193125-25-249348 | 001-37620 | 251414284 | 34 | 136084 | 1 | 1 |
| 2025-10-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-241416 | 001-37620 | 251397733 | 34 | 372332 | 1 | 1 |
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223697 | 001-37620 | 251357832 | 33 | 4304 | |||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223696 | 001-37620 | 251357831 | 33 | 4319 | |||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223695 | 001-37620 | 251357830 | 33 | 4379 | |||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223694 | 001-37620 | 251357829 | 33 | 4306 | |||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223693 | 001-37620 | 251357828 | 33 | 4289 | |||
| 2025-09-29 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-223692 | 001-37620 | 251357827 | 33 | 4310 | |||
| 2025-09-29 | 4 | 4 | 0001193125-25-223667 | 6085 | ||||||
| 2025-09-29 | 4 | 4 | 0001193125-25-223666 | 6672 | ||||||
| 2025-09-29 | 4 | 4 | 0001193125-25-223665 | 6666 | ||||||
| 2025-09-29 | 4 | 4 | 0001193125-25-223664 | 6681 | ||||||
| 2025-09-29 | 4 | 4 | 0001193125-25-223663 | 8105 | ||||||
| 2025-09-29 | 4 | 4 | 0001193125-25-223662 | 7524 | ||||||
| 2025-09-09 | 4 | xslF345X05/form4-09092025_080937.xml | 0001415889-25-023974 | 6619 | ||||||
| 2025-08-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003630 | 005-83933 | 251223538 | 34 | 10735 | |||
| 2025-08-14 | 4 | 4 | 0000950170-25-108844 | 8451 | ||||||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000522 | 005-83933 | 251216990 | 34 | 16157 | |||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105051 | 001-37620 | 251194281 | 34 | 8656760 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105024 | 001-37620 | 251194082 | 34 | 418379 | 1 | 1 |
| 2025-07-01 | 8-K | 8-K | 1.01 | 0001193125-25-153393 | 001-37620 | 251094090 | 34 | 141195 | 1 | 1 |
| 2025-06-18 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-142816 | 001-37620 | 251057891 | 34 | 4737268 | 1 | 1 |
| 2025-06-06 | S-8 | S-8 | 0000950170-25-083276 | 333-287866 | 251032169 | 33 | 310151 | |||
| 2025-06-06 | 4 | 4 | 0000950170-25-083041 | 5206 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-25-083046 | 001-37620 | 251030539 | 34 | 711727 | 1 | 1 |
| 2025-06-06 | 4 | 4 | 0000950170-25-083040 | 5190 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083037 | 5251 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083038 | 5191 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083039 | 5185 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083036 | 5240 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083035 | 5203 | ||||||
| 2025-06-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-133717 | 001-37620 | 251017075 | 34 | 4438824 | 1 | 1 |
| 2025-05-19 | 4 | 4 | 0000950170-25-074660 | 4903 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074659 | 5390 | ||||||
| 2025-05-19 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000329 | 001-37620 | 25963937 | 33 | 4455 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-013210 | 005-83933 | 25955060 | 34 | 19004 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002262 | 005-83933 | 25951967 | 34 | 10728 | |||
| 2025-05-02 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-002736 | 005-83933 | 25909965 | 34 | 19164 | |||
| 2025-05-01 | 10-Q | 10-Q | 0000950170-25-061848 | 001-37620 | 25903298 | 34 | 6854211 | 1 | 1 | |
| 2025-05-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-061836 | 001-37620 | 25903171 | 34 | 332286 | 1 | 1 |
| 2025-04-17 | ARS | ARS | 0000950170-25-055537 | 001-37620 | 25848129 | 34 | 24583371 | |||
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000619 | 005-83933 | 25844590 | 34 | 11078 | |||
| 2025-04-11 | DEFA14A | DEFA14A | 0000950170-25-053354 | 001-37620 | 25832845 | 34 | 6197798 | |||
| 2025-04-11 | DEF 14A | DEF 14A | 0000950170-25-053335 | 001-37620 | 25832803 | 34 | 18688227 | 1 | 1 | |
| 2025-03-24 | 4 | 4 | 0000950170-25-043903 | 6506 | ||||||
| 2025-03-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-002100 | 001-37620 | 25760789 | 33 | 5049 | |||
| 2025-02-28 | S-8 | S-8 | 0000950170-25-030015 | 333-285424 | 25690412 | 33 | 430969 | 1 | 1 | |
| 2025-02-28 | 10-K | 10-K | 0000950170-25-029975 | 001-37620 | 25689859 | 34 | 22182957 | 1 | 1 | |
| 2025-02-26 | 8-K | 8-K | 2.02 | 0000950170-25-027706 | 001-37620 | 25669927 | 34 | 372578 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001287 | 005-83933 | 25631252 | 34 | 10632 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-014236 | 005-83933 | 25630098 | 34 | 11885 | |||
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-001296 | 005-83933 | 25622508 | 34 | 18826 | |||
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-000176 | 005-83933 | 25617425 | 34 | 15672 | |||
| 2025-02-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-020831 | 001-37620 | 25593423 | 34 | 2890694 | 1 | 1 |
| 2025-02-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-000249 | 005-83933 | 25590374 | 34 | 39759 | |||
| 2025-02-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-000248 | 005-83933 | 25590371 | 34 | 24640 | |||
| 2025-01-28 | 4 | 4 | 0000950170-25-010137 | 10106 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-010121 | 9393 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-010120 | 6262 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-010118 | 4734 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-010117 | 6293 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-010116 | 4728 | ||||||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010114 | 001-37620 | 25566338 | 33 | 5681 | |||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010113 | 001-37620 | 25566336 | 33 | 4752 | |||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010111 | 001-37620 | 25566334 | 33 | 4316 | |||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010110 | 001-37620 | 25566333 | 33 | 5697 | |||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010109 | 001-37620 | 25566331 | 33 | 4775 | |||
| 2025-01-28 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-010108 | 001-37620 | 25566330 | 33 | 4309 | |||
| 2025-01-14 | 8-K | 8-K | 1.01,2.03 | 0001193125-25-006197 | 001-37620 | 25529781 | 34 | 147000 | 1 | 1 |
| 2025-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-000069 | 005-83933 | 25519735 | 34 | 44877 | |||
| 2025-01-07 | 4 | xslF345X05/form4-01072025_100104.xml | 0001415889-25-001052 | 7163 | ||||||
| 2025-01-07 | 3 | xslF345X02/form3-01072025_100147.xml | 0001415889-25-001050 | 18922 | ||||||
| 2025-01-07 | 4 | xslF345X05/form4-01072025_100138.xml | 0001415889-25-001045 | 5495 | ||||||
| 2025-01-07 | 3 | xslF345X02/form3-01072025_100150.xml | 0001415889-25-001032 | 24024 | ||||||
| 2025-01-06 | 8-K | 8-K | 5.02,8.01 | 0001193125-25-002189 | 001-37620 | 25511710 | 34 | 146156 | 1 | 1 |
| 2025-01-06 | 4 | 4 | 0000950170-25-002072 | 9352 | ||||||
| 2025-01-06 | 4 | 4 | 0000950170-25-002062 | 6901 | ||||||
| 2025-01-06 | 4 | 4 | 0000950170-25-002056 | 6925 | ||||||
| 2025-01-06 | 4 | 4 | 0000950170-25-002049 | 5308 | ||||||
| 2025-01-06 | 4 | 4 | 0000950170-25-002046 | 5312 | ||||||
| 2024-12-20 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-283109 | 001-37620 | 241567972 | 34 | 334978 | 1 | 1 |
| 2024-12-05 | SC 13G | SC 13G | 0001104659-24-125975 | 005-83933 | 241530208 | 34 | 85640 | |||
| 2024-11-20 | 8-K | 8-K | 1.01 | 0001193125-24-262641 | 001-37620 | 241481385 | 34 | 160729 | 1 | 1 |
| 2024-11-19 | 4 | 4 | 0000950170-24-128558 | 5367 | ||||||
| 2024-11-18 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000561 | 001-37620 | 241471425 | 33 | 4461 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0000921895-24-002726 | 005-83933 | 241463246 | 34 | 280634 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119017 | 005-83933 | 241463201 | 34 | 70644 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123363 | 001-37620 | 241435952 | 34 | 5527398 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123321 | 001-37620 | 241435717 | 34 | 317284 | 1 | 1 |
| 2024-09-17 | 3 | 3 | 0000950170-24-107273 | 14365 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107272 | 7485 | ||||||
| 2024-09-17 | 8-K | 8-K | 5.02 | 0001193125-24-220529 | 001-37620 | 241304265 | 34 | 146674 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093997 | 001-37620 | 241188553 | 34 | 5594500 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093945 | 001-37620 | 241188359 | 34 | 314379 | 1 | 1 |
| 2024-06-07 | S-8 | S-8 | 0000950170-24-070722 | 333-280050 | 241030057 | 33 | 209943 | |||
| 2024-06-07 | 4 | 4 | 0000950170-24-070702 | 5211 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070700 | 5198 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070699 | 5199 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070698 | 5248 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070707 | 5193 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070697 | 5214 | ||||||
| 2024-06-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-24-070584 | 001-37620 | 241029269 | 34 | 658290 | 1 | 1 |
| 2024-05-24 | 8-K | 8-K | 8.01 | 0001193125-24-147030 | 001-37620 | 24984276 | 34 | 146821 | 1 | 1 |
| 2024-05-20 | 4 | 4 | 0000950170-24-062585 | 5608 | ||||||
| 2024-05-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-003907 | 001-37620 | 24964779 | 33 | 4931 | |||
| 2024-05-02 | SC 13G | SC 13G | 0001104659-24-056418 | 005-83933 | 24909068 | 34 | 65933 | |||
| 2024-05-02 | 10-Q | 10-Q | 0000950170-24-052136 | 001-37620 | 24908476 | 34 | 5016838 | 1 | 1 | |
| 2024-05-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-052109 | 001-37620 | 24908302 | 34 | 286852 | 1 | 1 |
| 2024-04-18 | ARS | ARS | 0000950170-24-045542 | 001-37620 | 24854324 | 34 | 14249700 | |||
| 2024-04-12 | DEFA14A | DEFA14A | 0000950170-24-044067 | 001-37620 | 24841823 | 34 | 1930804 | |||
| 2024-04-12 | DEF 14A | DEF 14A | 0000950170-24-044066 | 001-37620 | 24841822 | 34 | 7281350 | 1 | 1 | |
| 2024-02-29 | UPLOAD | filename1.pdf | 0000000000-24-001681 | 333-276995 | 40434 | |||||
| 2024-02-27 | S-8 | S-8 | 0001193125-24-048048 | 333-277411 | 24687928 | 33 | 107310 | |||
| 2024-02-27 | 10-K | 10-K | 0000950170-24-021094 | 001-37620 | 24686495 | 34 | 11362720 | 1 | 1 | |
| 2024-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-021087 | 001-37620 | 24686381 | 34 | 322589 | 1 | 1 |
| 2024-02-15 | 424B3 | 424B3 | 0001193125-24-037523 | 333-276995 | 24643692 | 33 | 167793 | |||
| 2024-02-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-02-14 16:00:00 | 9999999995-24-000473 | 333-276995 | 24641903 | 33 | 1840 | ||
| 2024-02-14 | SC 13G/A | kura13ga2024.htm | 0000935836-24-000213 | 005-83933 | 24641008 | 34 | 47590 | |||
| 2024-02-14 | CORRESP | filename1.htm | 0001193125-24-035631 | 7402 | ||||||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-000441 | 005-83933 | 24633196 | 34 | 277421 | |||
| 2024-02-13 | SC 13G/A | d10964193_13g-a.htm | 0000919574-24-001075 | 005-83933 | 24630135 | 34 | 109449 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021309 | 005-83933 | 24628775 | 34 | 13125 | |||
| 2024-02-13 | CORRESP | filename1.htm | 0001193125-24-033677 | 7684 | ||||||
| 2024-02-12 | SC 13G/A | e619259_sc13ga-kura.htm | 0001193805-24-000194 | 005-83933 | 24621532 | 34 | 101062 | |||
| 2024-02-09 | S-3 | S-3 | 0001193125-24-030329 | 333-276995 | 24616231 | 33 | 307001 | |||
| 2024-02-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001845459-24-000001 | 021-504346 | 24593592 | 33 | 15030 | ||
| 2024-01-31 | 4 | 4 | 0000950170-24-009496 | 8552 | ||||||
| 2024-01-31 | 4 | 4 | 0000950170-24-009495 | 4705 | ||||||
| 2024-01-31 | 4 | 4 | 0000950170-24-009494 | 4921 | ||||||
| 2024-01-31 | 4 | 4 | 0000950170-24-009493 | 8344 | ||||||
| 2024-01-30 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000055 | 001-37620 | 24578236 | 33 | 4457 | |||
| 2024-01-30 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-018713 | 001-37620 | 24575797 | 34 | 12374437 | 1 | 1 |
| 2024-01-26 | 4 | 4 | 0000950170-24-008020 | 10389 | ||||||
| 2024-01-26 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-24-016715 | 001-37620 | 24567811 | 34 | 803185 | 1 | 1 |
| 2024-01-24 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000042 | 001-37620 | 24556535 | 33 | 4516 | |||
| 2024-01-24 | SC 13G/A | us50127t1097_012424.txt | 0001086364-24-002271 | 005-83933 | 24555793 | 34 | 13710 | |||
| 2024-01-23 | SC 13G/A | Kura_Oncology_Inc.txt | 0000093751-24-000076 | 005-83933 | 24550608 | 34 | 8543 | |||
| 2024-01-04 | 4 | 4 | 0000950170-24-001850 | 7862 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001849 | 6926 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001846 | 5309 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001847 | 7082 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001843 | 5304 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001842 | 5313 | ||||||
| 2023-12-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-301830 | 001-37620 | 231507397 | 34 | 345237 | 1 | 1 |
| 2023-12-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-058040 | 7073 | ||||||
| 2023-11-02 | S-3ASR | S-3ASR | 0001193125-23-269431 | 333-275279 | 231373101 | 33 | 1246717 | |||
| 2023-11-02 | 10-Q | 10-Q | 0000950170-23-058173 | 001-37620 | 231372199 | 34 | 7828856 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-058157 | 001-37620 | 231372101 | 34 | 359980 | 1 | 1 |
| 2023-09-21 | SC 13G | e618952_sc13g-kura.htm | 0001193805-23-001309 | 005-83933 | 231269607 | 34 | 100275 | |||
| 2023-09-01 | 8-K | 8-K | 1.01 | 0001193125-23-227632 | 001-37620 | 231232509 | 34 | 144130 | 1 | 1 |
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046002 | 5529 | ||||||
| 2023-08-16 | 3 | FORM 3 SUBMISSION | 0001209191-23-046001 | 6681 | ||||||
| 2023-08-09 | 10-Q | 10-Q | 0000950170-23-040556 | 001-37620 | 231155183 | 34 | 7686836 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-037994 | 001-37620 | 231140150 | 34 | 389335 | 1 | 1 |
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-038797 | 4963 | ||||||
| 2023-06-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-166858 | 001-37620 | 231014163 | 34 | 658504 | 1 | 1 |
| 2023-06-14 | 424B5 | 424B5 | 0001193125-23-166854 | 333-251172 | 231014142 | 33 | 575638 | |||
| 2023-06-13 | 424B5 | 424B5 | 0001193125-23-166029 | 333-251172 | 231011318 | 33 | 556476 | |||
| 2023-06-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-164835 | 001-37620 | 231007028 | 34 | 2999432 | 1 | 1 |
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033892 | 17273 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033888 | 5355 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033879 | 5343 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033871 | 5342 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033859 | 5392 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033850 | 5337 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033836 | 5358 | ||||||
| 2023-06-02 | S-8 | S-8 | 0000950170-23-026101 | 333-272389 | 23989467 | 33 | 260280 | |||
| 2023-06-02 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-23-026086 | 001-37620 | 23989099 | 34 | 796410 | 1 | 1 |
| 2023-05-10 | 10-Q | 10-Q | 0000950170-23-020526 | 001-37620 | 23906564 | 34 | 6936013 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020508 | 001-37620 | 23906352 | 34 | 344535 | 1 | 1 |
| 2023-05-04 | DEFA14A | DEFA14A | 0000950170-23-017830 | 001-37620 | 23888581 | 34 | 56676 | |||
| 2023-04-20 | ARS | ARS | 0000950170-23-013674 | 001-37620 | 23833145 | 34 | 5819449 | |||
| 2023-04-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-105746 | 001-37620 | 23828532 | 34 | 161549 | 1 | 1 |
| 2023-04-06 | DEFA14A | DEFA14A | 0000950170-23-012102 | 001-37620 | 23806932 | 34 | 1922713 | |||
| 2023-04-06 | DEF 14A | DEF 14A | 0000950170-23-012096 | 001-37620 | 23806861 | 34 | 5017664 | 1 | 1 | |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001193125-23-067513 | 001-37620 | 23723347 | 34 | 143912 | 1 | 1 |
| 2023-02-24 | S-8 | S-8 | 0000950170-23-004192 | 333-269974 | 23661360 | 33 | 265767 | |||
| 2023-02-23 | 10-K | 10-K | 0000950170-23-004107 | 001-37620 | 23659749 | 34 | 15197013 | 1 | 1 | |
| 2023-02-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-004098 | 001-37620 | 23659643 | 34 | 391268 | 1 | 1 |
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011289 | 7913 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011287 | 7181 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011285 | 5426 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011283 | 7206 | ||||||
| 2023-02-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-011276 | 18003 | ||||||
| 2023-02-21 | CT ORDER | filename1.pdf | 20230221,20230221 | 9999999997-23-000629 | 001-37620 | 23646036 | 34 | 130941 | ||
| 2023-02-14 | SC 13G/A | KURA ONCOLOGY, INC. | 0000902664-23-001670 | 005-83933 | 23623463 | 34 | 59024 | |||
| 2023-02-14 | SC 13G/A | deeptrack-kura123122a1.htm | 0001172661-23-000840 | 005-83933 | 23622987 | 34 | 102965 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000477 | 005-83933 | 23620675 | 34 | 276988 | |||
| 2023-02-13 | SC 13G/A | d9927321_13g-a.htm | 0000919574-23-001040 | 005-83933 | 23616449 | 34 | 123756 | |||
| 2023-02-10 | SC 13G/A | kura13ga2022.htm | 0000935836-23-000102 | 005-83933 | 23610291 | 34 | 47156 | |||
| 2023-02-10 | SC 13G/A | e618248_sc13ga-ko.htm | 0001193805-23-000149 | 005-83933 | 23609060 | 34 | 99487 | |||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-016317 | 005-83933 | 23603566 | 34 | 13015 | |||
| 2023-02-03 | SC 13G/A | Kura_Oncology_Inc.txt | 0000093751-23-000145 | 005-83933 | 23584792 | 34 | 8488 | |||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005753 | 4849 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005748 | 4862 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005746 | 7490 | ||||||
| 2023-01-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-005744 | 7057 | ||||||
| 2023-01-31 | SC 13G/A | us50127t1097_013123.txt | 0001306550-23-005107 | 005-83933 | 23571810 | 34 | 13450 | |||
| 2023-01-13 | 8-K | 8-K | 5.02 | 0001193125-23-008358 | 001-37620 | 23528889 | 34 | 144928 | 1 | 1 |
| 2023-01-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-23-004159 | 001-37620 | 23516627 | 34 | 13953670 | 1 | 1 |
| 2022-12-12 | 8-K | 8-K | 8.01 | 0001193125-22-302283 | 001-37620 | 221456165 | 34 | 154117 | 1 | 1 |
| 2022-12-05 | SC 13G | THE SCHEDULE 13G | 0000921895-22-003161 | 005-83933 | 221445586 | 34 | 285366 | |||
| 2022-11-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-057874 | 5490 | ||||||
| 2022-11-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-276906 | 001-37620 | 221358235 | 34 | 171093 | 1 | 1 |
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021605 | 001-37620 | 221356497 | 34 | 7451383 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021564 | 001-37620 | 221356287 | 34 | 413988 | 1 | 1 |
| 2022-11-03 | 8-K | 8-K | 1.01,2.03,3.02,7.01,9.01 | 0001193125-22-276373 | 001-37620 | 221356199 | 34 | 1093912 | 1 | 1 |
| 2022-11-03 | 424B5 | 424B5 | 0001193125-22-276361 | 333-251172 | 221356161 | 33 | 446914 | |||
| 2022-09-29 | 8-K | 8-K | 5.02 | 0001193125-22-254305 | 001-37620 | 221280550 | 34 | 152317 | 1 | 1 |
| 2022-08-03 | 10-Q | 10-Q | 0000950170-22-014251 | 001-37620 | 221132728 | 34 | 6888449 | 1 | 1 | |
| 2022-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-014242 | 001-37620 | 221132643 | 34 | 415771 | 1 | 1 |
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038944 | 8912 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038936 | 8919 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038931 | 8913 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038926 | 8925 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038922 | 8912 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038917 | 8967 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038913 | 8911 | ||||||
| 2022-06-23 | 8-K | 8-K | 5.07 | 0000950170-22-012040 | 001-37620 | 221035935 | 34 | 229250 | 1 | 1 |
| 2022-05-04 | 10-Q | 10-Q | 0000950170-22-007404 | 001-37620 | 22891973 | 34 | 6288138 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007388 | 001-37620 | 22891694 | 34 | 341364 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0000950170-22-006540 | 001-37620 | 22866689 | 34 | 1915483 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0000950170-22-006529 | 001-37620 | 22866502 | 34 | 2440636 | |||
| 2022-03-10 | SC 13G/A | filing.txt | 0000315066-22-001482 | 005-83933 | 22727729 | 34 | 8057 | |||
| 2022-02-24 | S-8 | S-8 | 0001564590-22-006787 | 333-263000 | 22672887 | 33 | 214254 | |||
| 2022-02-24 | 8-K | 8-K | 1.01,1.02,9.01 | 0001193125-22-052342 | 001-37620 | 22672217 | 34 | 480023 | 1 | 1 |
| 2022-02-24 | 424B5 | 424B5 | 0001193125-22-052332 | 333-251172 | 22672140 | 33 | 504999 | |||
| 2022-02-24 | 10-K | 10-K | 0000950170-22-001967 | 001-37620 | 22671055 | 34 | 11966246 | 1 | 1 | |
| 2022-02-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-001964 | 001-37620 | 22670960 | 34 | 363084 | 1 | 1 |
| 2022-02-11 | SC 13G/A | d9166351_13g-a.htm | 0000919574-22-000916 | 005-83933 | 22622251 | 34 | 127101 | |||
| 2022-02-11 | SC 13G | KURA_ONCOLOGY_INC.txt | 0000093751-22-000296 | 005-83933 | 22619264 | 34 | 8529 | |||
| 2022-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-008156 | 7912 | ||||||
| 2022-02-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-008153 | 10539 | ||||||
| 2022-02-04 | SC 13G | deeptrack-kura012822.htm | 0001172661-22-000237 | 005-83933 | 22590710 | 34 | 103008 | |||
| 2022-02-03 | SC 13G/A | us50127t1097_020222.txt | 0000834237-22-005417 | 005-83933 | 22585655 | 34 | 13480 | |||
| 2022-02-01 | 8-K | 8-K | 5.02 | 0001193125-22-024600 | 001-37620 | 22579088 | 34 | 150705 | 1 | 1 |
| 2022-01-31 | SC 13G | kuraoncology13g.htm | 0000935836-22-000043 | 005-83933 | 22574511 | 34 | 47160 | |||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005391 | 10768 | ||||||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005380 | 10959 | ||||||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005374 | 11005 | ||||||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005367 | 10805 | ||||||
| 2022-01-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-005360 | 9057 | ||||||
| 2022-01-20 | 8-K | 8-K | 8.01 | 0001193125-22-013806 | 001-37620 | 22542552 | 34 | 143438 | 1 | 1 |
| 2022-01-10 | SC 13G/A | filing.txt | 0000315066-22-000039 | 005-83933 | 22520721 | 34 | 8540 | |||
| 2021-12-09 | SC 13G | d9061703_13g.htm | 0000919574-21-007370 | 005-83933 | 211482340 | 34 | 119906 | |||
| 2021-12-03 | SC 13G | e621131_sc13g-ko.htm | 0001193805-21-001689 | 005-83933 | 211469746 | 34 | 99684 | |||
| 2021-11-24 | 8-K | 8-K | 8.01 | 0001193125-21-339334 | 001-37620 | 211441248 | 34 | 143731 | 1 | 1 |
| 2021-11-04 | 10-Q | 10-Q | 0001564590-21-054494 | 001-37620 | 211380211 | 34 | 6685523 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-054488 | 001-37620 | 211380097 | 34 | 361890 | 1 | 1 |
| 2021-10-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-060952 | 5458 | ||||||
| 2021-10-19 | 3 | FORM 3 SUBMISSION | 0001209191-21-060950 | 6649 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001564590-21-041601 | 001-37620 | 211148440 | 34 | 12638637 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-041588 | 001-37620 | 211148278 | 34 | 363024 | 1 | 1 |
| 2021-07-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-048540 | 7655 | ||||||
| 2021-07-29 | 3 | FORM 3 SUBMISSION | 0001209191-21-048535 | 6613 | ||||||
| 2021-07-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-228185 | 001-37620 | 211124849 | 34 | 173073 | 1 | 1 |
| 2021-06-25 | 8-K | 8-K | 5.07 | 0001564590-21-034591 | 001-37620 | 211047963 | 34 | 205225 | 1 | 1 |
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042792 | 5312 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042790 | 5311 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042788 | 5324 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042785 | 5308 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042782 | 5361 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042779 | 5306 | ||||||
| 2021-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-042777 | 5348 | ||||||
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-038237 | 5349 | ||||||
| 2021-06-04 | 3 | FORM 3 SUBMISSION | 0001209191-21-038227 | 6618 | ||||||
| 2021-06-04 | DEFA14A | DEFA14A | 0001193125-21-182090 | 001-37620 | 21994873 | 34 | 24161 | |||
| 2021-06-04 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-182056 | 001-37620 | 21994870 | 34 | 174240 | 1 | 1 |
| 2021-05-24 | 8-K | 8-K | 1.02 | 0001564590-21-029533 | 001-37620 | 21955498 | 34 | 165140 | 1 | 1 |
| 2021-05-17 | 8-K | 8-K | 1.01,2.03 | 0001564590-21-028255 | 001-37620 | 21928993 | 34 | 166570 | 1 | 1 |
One latest value per concept from companyfacts (316 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 91.88M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 496.10M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.61M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001193125-26-151335 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.29M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001193125-26-151335 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 6.49M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001193125-26-151335 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.74M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001193125-26-151335 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 83.72 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001193125-26-151335 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 0 | 2026-11-10 | S-3ASR | 2026-11-10 | 0001193125-26-455759 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 13,050 | 2026-11-10 | S-3ASR | 2026-11-10 | 0001193125-26-455759 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 150.00M | 2026-11-10 | S-3ASR | 2026-11-10 | 0001193125-26-455759 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 13,050 | 2026-11-10 | S-3ASR | 2026-11-10 | 0001193125-26-455759 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-10 | S-3ASR | 2026-11-10 | 0001193125-26-455759 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 66.79M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263589 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 1.40M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-03 | 0000950170-22-014251 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 8.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 1.06M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 14.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 31,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-04 | 0001564590-20-020836 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 66.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 14.11M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007404 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 3.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | USD | -2.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 1.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 49,500 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.41B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 8.17M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 294,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 2.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 24.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 334,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 23.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | Assets | Assets | USD | 566.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 534.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 0 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 21,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-07 | 0001564590-16-027950 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 10,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-07 | 0001564590-16-027950 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 67.77M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-07 | 0001564590-16-027950 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 8,100 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-050880 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 102.40M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026848 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 166.85M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026848 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 56.80M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-11 | 0001564590-16-019115 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 332.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost | Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | USD | 9.30M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 434.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 0 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026848 |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | security | 22 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054494 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 2.03M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263589 |
| us-gaap | Cash | Cash | USD | 53.57M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-13 | 0001564590-15-004193 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 57.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 105.96M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-01 | 0001564590-19-027967 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 57.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -91.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 4.00M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-07 | 0001564590-16-027950 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 91.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 91.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 9,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -215.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 63.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 380.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 2.04M | 2014-12-31 | 2015 | Q1 | 10-Q | 2015-05-13 | 0001564590-15-004193 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 876,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 288.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 7.25M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.06 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 |
| us-gaap | DebtInstrumentInterestRateIncreaseDecrease | Debt Instrument, Interest Rate, Increase (Decrease) | pure | 0.05 | 2022-11-02 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 300,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054494 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | Security | 36 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001967 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 328.00M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-03 | 0000950170-22-014251 | |
| us-gaap | DebtSecuritiesAvailableForSaleGainLoss | Debt Securities, Available-for-sale, Gain (Loss) | USD | 0 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 411.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 60 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | DebtSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment | Debt Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment | USD | 0 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 |
| us-gaap | DeconsolidationGainOrLossAmount | Deconsolidation, Gain (Loss), Amount | USD | 30.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 594,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 367.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 7.94M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.34M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0000950170-23-004107 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 111.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 10.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsOtherComprehensiveLoss | Deferred Tax Assets, Other Comprehensive Loss | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 67.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 10.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 4.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 363.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 1.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | DeferredTaxLiabilitiesOtherComprehensiveIncome | Deferred Tax Liabilities, Other Comprehensive Income | USD | 247,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | Depreciation | Depreciation | USD | 1.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -268,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 232,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 232,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 204,691 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | DueToOfficersOrStockholdersCurrent | Due to Officers or Stockholders, Current | USD | 15,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | DueToOtherRelatedPartiesNoncurrent | Due to Other Related Parties, Noncurrent | USD | 7,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.49 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007404 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.272 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.023 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.031 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 18.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 18.00M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026848 | |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -212,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021094 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 80.84M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263589 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -278.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -211.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -30.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 2.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 13,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-28 | 0001144204-13-018035 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 75.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 9.52M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -58.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 116,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 6.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -309,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 264,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 8.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 3.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 14.81M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263589 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | 923,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 5.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | 1,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-04 | 0001564590-20-020836 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 8,900 | 2007-11-16 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 5.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -30.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 196,000 | 2014-08-23 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 24,002 | 2007-11-16 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 4.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 5.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 1,500 | 2007-11-16 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-15 | 0001144204-12-029113 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -226,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021605 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 605,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -907,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-13 | 0001564590-15-004193 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -9.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 664,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-13 | 0001564590-15-004193 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | 33.88M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263589 |
| us-gaap | InterestAndDebtExpense | Interest and Debt Expense | USD | 414,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054494 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 15.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | InterestExpense | Interest Expense | USD | 804,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-093997 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 46,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 627,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 998,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 24,002 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 1.09M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 | |
| us-gaap | InterestReceivable | Interest Receivable | USD | 3.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 4.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 450,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011824 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 22.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 7.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 3.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 509,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 6.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | Liabilities | Liabilities | USD | 548.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 566.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 148.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 6,000 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-11 | 0001564590-16-019115 | |
| us-gaap | LineOfCreditFacilityCommitmentFeeAmount | Line of Credit Facility, Commitment Fee Amount | USD | 300,000 | 2017-11-01 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 | |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 20.00M | 2017-05-31 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 | |
| us-gaap | LineOfCreditFacilityRemainingBorrowingCapacity | Line of Credit Facility, Remaining Borrowing Capacity | USD | 12.50M | 2016-04-27 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022269 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 9.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 8.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 2.33M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 3.32M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0000950170-23-004107 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 3.90M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021094 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 3.86M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 3.81M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 161,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022269 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 1.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -82,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006263 |
| us-gaap | MinorityInterestOwnershipPercentageByParent | Noncontrolling Interest, Ownership Percentage by Parent | pure | 1 | 2015-03-06 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001564590-15-007408 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 34.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 57.65M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011824 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 77.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -29.71M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011824 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -202.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -12.85M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011824 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -211.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 14.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 2.04M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 493,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 371.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -226.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 503,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0000950170-23-004107 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 16.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 14.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 741,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-05 | 0001564590-19-006263 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 500,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 159,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 159,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 159,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 300,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.50M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054494 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.124 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 24,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 3.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 17.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -3.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -971,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 260,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | 210,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-01 | 0000950170-25-061848 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 3.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 534,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001564590-15-007408 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 73,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0000950170-23-004107 |
| us-gaap | PaymentsForDerivativeInstrumentInvestingActivities | Payments for Derivative Instrument, Investing Activities | USD | 232,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 611,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021094 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 575,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 |
| us-gaap | PaymentsToAcquireEquitySecuritiesFvNi | PaymentsToAcquireEquitySecuritiesFvNi | USD | 4.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 418.46M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123363 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 304.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-15 | 0001144204-13-029422 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 23.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 707,000 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-13 | 0001564590-15-004193 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 4.29M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 31.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 5.00M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001564590-15-007408 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 10.00M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 303,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007404 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 172,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 |
| us-gaap | ProceedsFromLeasePayments | Proceeds from Lease Payment, Operating Activity | USD | 900,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 387.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 710,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 411.93M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123363 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 6.00M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 829,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-06 | 0001564590-21-024989 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 2.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 30,000 | 2015-03-05 | 2015-03-06 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 11.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 7.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | USD | 69,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 7.25M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021094 |
| us-gaap | RepaymentsOfLongTermLinesOfCredit | Repayments of Long-term Lines of Credit | USD | 344,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-25 | 0001564590-20-006391 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 10,000 | 2007-11-16 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 194.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 210,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-09 | 0000950170-23-040556 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 200,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-093997 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.39B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 61.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 93.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 24.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 15.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | USD | 9.81M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029975 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 277,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 11.74 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 1.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.79 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 11.1 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 401,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 14.91 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.708 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.018 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 1.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 13.35M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2015-07-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-13 | 0001564590-15-010719 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.76 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001564590-18-005293 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 17.25 | 2024-01-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219481 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 17.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.5 | 2015-03-05 | 2015-03-06 | 2015 | FY | 10-K | 2016-03-17 | 0001564590-16-014998 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 1.38M | 2024-01-01 | 2024-01-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001193125-26-219481 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 7.62M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-14 | 0001564590-17-004291 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeBenefitPlan | Stock Issued During Period, Value, Employee Benefit Plan | USD | 303,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007404 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 31.54M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.01M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2.26M | 2021-07-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054494 |
| us-gaap | StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-007822 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 59,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-346884 | |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 1.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-04 | 0001564590-20-020836 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 25.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 10.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 67,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001193125-26-092567 |
| us-gaap | UnsecuredDebt | Unsecured Debt | USD | 15,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-27 | 0001213900-15-001429 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 47.90M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021094 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 89.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 66.61M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007404 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 3.90M | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-14 | 0001564590-15-007408 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 89.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-455455 |